Thrombolytic Therapy Monitoring and Complications
Key Takeaways
- Current acute ischemic stroke guidance supports IV thrombolysis with alteplase or tenecteplase for eligible patients within the 4.5-hour window, with advanced-imaging selection for some later or unknown-onset cases.
- Nursing contraindication awareness focuses on hemorrhage on imaging, active bleeding, recent intracranial or spinal surgery or trauma, severe uncontrolled hypertension, significant coagulopathy, and medication-related bleeding risk.
- Blood pressure must meet protocol thresholds before thrombolytic therapy and must be monitored closely afterward without pursuing overly intensive systolic lowering below 140 mm Hg.
- Frequent neurologic and blood pressure checks after thrombolysis are designed to catch intracranial hemorrhage, systemic bleeding, angioedema, and neurologic worsening early.
- Severe headache, vomiting, acute hypertension, worsening neurologic status, or tongue/lip swelling during thrombolytic therapy requires stopping the exposure if infusing, urgent notification, and airway or imaging preparation.
The nurse protects both speed and safety
Intravenous thrombolysis is time-sensitive, but it is not a shortcut around safety screening. Current acute ischemic stroke guidance supports alteplase or tenecteplase for eligible patients in the 4.5-hour window, and supports advanced-imaging selection for some patients with unknown onset or later presentation. Local protocol determines the agent, dose process, and documentation requirements.
The nurse's contribution is practical and decisive: confirm last known well, weight or dosing weight, glucose, baseline NIHSS, vital signs, medication history, anticoagulant use and last dose, allergies, recent surgery or trauma, bleeding history, pregnancy status when relevant, IV access, and consent or surrogate contact as required by policy. These tasks should run in parallel with imaging and provider decision-making.
Contraindication awareness
SCRN candidates should recognize major red flags even though the provider makes the final treatment decision. Intracranial hemorrhage on imaging, active internal bleeding, recent intracranial or spinal surgery, serious head trauma, severe uncontrolled hypertension, very low platelets, or abnormal coagulation related to anticoagulants can make thrombolysis unsafe. Recent major surgery, recent gastrointestinal bleeding, intracranial tumor concerns, and rapidly improving symptoms require careful risk-benefit review rather than casual dismissal.
| Screening concern | Why the nurse escalates it |
|---|---|
| BP above protocol threshold | Increases hemorrhage risk and must be treated before thrombolysis |
| Anticoagulant use or elevated INR | May make systemic lysis unsafe |
| Platelets below protocol threshold | Raises serious bleeding risk |
| Active bleeding or recent major surgery | Raises systemic hemorrhage risk |
| Severe headache before treatment | Could suggest hemorrhage or alternate diagnosis |
| Non-disabling deficit only | May favor non-thrombolytic management under current guidance |
Monitoring after treatment begins
During and after thrombolytic therapy, neurologic assessment and blood pressure monitoring become the nurse's central work. Many protocols use checks every 15 minutes during treatment and early recovery, then every 30 minutes, then hourly through the first 24 hours. Follow the local order set exactly because these intervals also define when complications should be recognized.
Avoid unnecessary invasive procedures. Do not start antiplatelet or anticoagulant therapy until the post-treatment safety window and follow-up imaging requirements are met by protocol. Keep the patient NPO until swallowing is cleared. Maintain fall precautions, bleeding precautions, and clear handoff documentation.
Complications that cannot wait
The most feared complication is symptomatic intracranial hemorrhage. Sudden severe headache, vomiting, acute hypertension, decreased level of consciousness, seizure, or neurologic worsening should trigger immediate escalation and emergent imaging. If alteplase is infusing, expect the order to stop it while the team evaluates. Prepare labs, reversal or blood-product workflows if ordered, and airway support as needed.
Orolingual angioedema is another high-risk event, especially in patients with angiotensin-converting enzyme inhibitor exposure. Tongue, lip, or airway swelling during thrombolytic therapy is an airway emergency. Stop the infusion if applicable, call for immediate help, monitor airway and oxygenation, and prepare emergency medications and airway equipment per protocol.
Systemic bleeding can appear as bleeding gums, hematuria, hematemesis, melena, access-site bleeding, or expanding bruising. Minor oozing still deserves documentation and trending, but major bleeding requires urgent notification. On the exam, the safest choice pairs focused assessment with immediate escalation rather than passive observation.
A thrombolytic-eligible patient has blood pressure of 196/112 mm Hg before treatment. What should the nurse anticipate?
Ten minutes into an alteplase infusion, a patient develops tongue swelling and muffled speech. What is the priority action?
Which order should the nurse question during the first 24 hours after thrombolytic therapy unless specifically cleared by protocol?